#compounding
13 pieces tagged compounding.
The moleculesSermorelin vs ipamorelin vs CJC-1295Sermorelin and CJC-1295 are GHRH analogues; ipamorelin is a five-residue ghrelin-receptor ligand. One had an approved product that was discontinued, two have none. Identity and status side by side.
Where the line isThe oxytocin nasal spray approval history, with datesThere is no FDA-approved oxytocin nasal spray. The only nasal application ever listed, NDA 012285 Syntocinon, had its approval withdrawn effective September 8, 1997. What the record shows as of September 23, 2026.
Where the line isGlutathione's US regulatory status, with datesNo approved drug product contains reduced glutathione. What is approved, where glutathione sits on FDA's compounding lists, what the 2022 committee vote decided, and what the two FDA alerts actually say.
The moleculesSemax and Selank: two heptapeptides and their US statusSemax (MEHFPGP) is four residues of ACTH plus a Pro-Gly-Pro tail; Selank (TKPRPGP) is the tetrapeptide tuftsin plus the same tail. Where each came from, what the spelling variants mean, and their status as of September 2026.
The moleculesNAD+, 5-amino-1MQ and glutathione: which are peptides?Three catalog staples that share a shelf with peptides. Only one is a peptide. What each molecule actually is, from PubChem, and why the distinction changes what a certificate should show.
The moleculesMelanotan II, PT-141 and afamelanotide: one parent, three analoguesAfamelanotide, Melanotan II and bremelanotide all descend from the 13-residue hormone alpha-MSH. Two became approved drugs; Melanotan II never did. Structures, lineage, FDA's own words on MT-II, and status as of September 2026.
The moleculesGHK-Cu: why the powder is blue and what copper peptide meansGHK-Cu is the tripeptide glycyl-histidyl-lysine holding one copper(II) ion. The copper is what makes it blue, what makes it a different molecule from GHK, and what its two INCI names are about. Status as of September 2026.
Where the line isFDA approved peptides in 2026: a status table with dates and sourcesWhich peptides have an FDA-approved product, which are investigational and which have neither, as of October 21, 2026. Every row carries a date and a primary source, with short answers for ipamorelin and BPC-157.
The moleculesEpithalon, epitalon and the word bioregulatorOne tetrapeptide, four spellings, and a term that is not a pharmacological class. What AEDG is, where it came from, what the Khavinson school means by bioregulator, and its US status as of September 21, 2026.
Where the line isCategory 1, Category 2 and the 503A bulks list in 2026Twelve peptides left FDA's Category 2 in April, GHK-Cu went back into Category 1 in May, and an advisory committee voted in July. None of it put a peptide on the 503A bulks list. A dated tracker.
Where the line isIs BPC-157 legal? FDA status, Category 2 and WADA in 2026BPC-157 is not banned in US law, not FDA approved and not compoundable under 503A. Its Category 2 history, the July 2026 committee vote and WADA S0, each dated to its source, as of October 2026.
Where the line isAre peptides legal in the US? A dated answer for 2026Peptides are not controlled substances, and research use only sale is lawful when nothing points to use in people. Approval, compounding, supplements, import and sport, each dated.
Where the line isCompounding pharmacy, outsourcing facility or research supplierA 503A pharmacy, a 503B outsourcing facility and a research supplier operate under three different sets of rules. What each one is, why a pharmacy cannot compound BPC-157 today, and why a research vial has no place in the other two chains.
Nothing here is medical advice. Everything on this site is supplied for laboratory research use only.